Aulimanid

澳利莫迪

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameAulimanid
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell wall inhibitorsDNA synthesis inhibitors
TargetsDNA
Therapy Area/IndicationsTuberculosis, PulmonaryTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Changao Pharmaceutical Science And Technologyco Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNanjing Changao Pharmaceutical Science And Technologyco LtdShanghai Sun-Sail Pharmaceutical Science & Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsTuberculosis, PulmonaryTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A